Hello
@dr enlander, welcome to the forum. I am pleased that you have joined us as it will, I hope, enable us to learn more about the clinical trial you are running for K pressin.
I have just re-watched your video linked at the start of this thread. I hope you will understand that, for someone like me who has been sick for 30 years, seeing what comes across as a advertisement for a bottle of unnamed ingredients does not seem like a good way to make me feel confident I would want to buy it.
We are faced every day with protocols, remedies, 'cures' and treatments. The on-line world is full of people trying to sell us stuff. At the moment we have no way of distinguishing Kpressin from the rest.
I have a few questions I would be grateful if you could answer.
1. On this forum our interest is in science, and evidence based medicine. I am pleased to hear you are doing a clinical trial. It would be a great help to us if you would let us know what stage it is at. All you say on the video is that you are 'taking note from patients using it to give a report later in the year'.
Can you be more specific? Is it a pilot study, or a full trial? Is it double blinded, is there a control group, and what are your primary and secondary outcome measures? Is there a registered protocol we can read?
2. I note also that you say on the video that you believe ME/CFS is a 'problem of an abnormal methylation cycle in the immune system'. I would be interested to learn more about the basis for this. Can you point us to the research papers supporting it?
3. And finally, you describe Kpressin as an oral version of kutapressin and hepapressin. Can you give us a link to the research done showing effectiveness of either of these?
Thank you.